BIONANO GENOMICS INC (BNGO) Stock Price, Forecast & Analysis
NASDAQ:BNGO • US09075F4046
BNGO Key Statistics, Chart & Performance
The current stock price of BNGO is 1.15 USD. In the past month the price decreased by -23.84%. In the past year, price decreased by -72.36%.
BNGO Technical Analysis
BNGO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BNGO. The financial health of BNGO is average, but there are quite some concerns on its profitability.
BNGO Financial Highlights
Over the last trailing twelve months BNGO reported a non-GAAP Earnings per Share(EPS) of -20.56. The EPS increased by 77.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.81% | ||
| ROE | -77.49% | ||
| Debt/Equity | 0.07 |
BNGO Forecast & Estimates
9 analysts have analysed BNGO and the average price target is 7.65 USD. This implies a price increase of 565.22% is expected in the next year compared to the current price of 1.15.
For the next year, analysts expect an EPS growth of 92.31% and a revenue growth -2.01% for BNGO
BNGO Ownership
BNGO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.95 | 192.995B | ||
| DHR | DANAHER CORP | 24.65 | 148.11B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 146.99 | 47.72B | ||
| A | AGILENT TECHNOLOGIES INC | 18.14 | 35.276B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.79 | 28.054B | ||
| IQV | IQVIA HOLDINGS INC | 13.04 | 27.46B | ||
| WAT | WATERS CORP | 22.31 | 19.016B | ||
| ILMN | ILLUMINA INC | 24.61 | 18.622B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.73 | 17.832B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.6 | 12.341B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BNGO
Company Profile
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The company is headquartered in San Diego, California and currently employs 98 full-time employees. The company went IPO on 2018-08-01. The firm offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. The company also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The firm additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The firm markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Company Info
BIONANO GENOMICS INC
9540 Towne Centre Drive, Suite 100
San Diego CALIFORNIA 92121 US
CEO: R. Erik Holmlin
Employees: 99
Phone: 18588887600
BIONANO GENOMICS INC / BNGO FAQ
Can you describe the business of BIONANO GENOMICS INC?
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The company is headquartered in San Diego, California and currently employs 98 full-time employees. The company went IPO on 2018-08-01. The firm offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. The company also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The firm additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The firm markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Can you provide the latest stock price for BIONANO GENOMICS INC?
The current stock price of BNGO is 1.15 USD.
What is the dividend status of BIONANO GENOMICS INC?
BNGO does not pay a dividend.
What is the ChartMill technical and fundamental rating of BNGO stock?
BNGO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the analyst forecast for BNGO stock?
9 analysts have analysed BNGO and the average price target is 7.65 USD. This implies a price increase of 565.22% is expected in the next year compared to the current price of 1.15.
Can you provide the sector and industry classification for BIONANO GENOMICS INC?
BIONANO GENOMICS INC (BNGO) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Is BIONANO GENOMICS INC (BNGO) expected to grow?
The Revenue of BIONANO GENOMICS INC (BNGO) is expected to decline by -2.01% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.